Prostate cancer is the most frequent cancer and the second-leading cause of cancer deaths for males in the United States. One in every six men is diagnosed with the disease and, as the male population ages, the incidence of prostate cancer is expected to increase. If found early, prostate cancer is typically treated with prostatectomy or radiation therapy. However, the challenge in treating this disease is the ability to distinguish slow-growing prostate cancer from more aggressive types. This distinction affects treatment decisions.
MD Anderson’s prostate cancer moon shot will apply our current knowledge and experience with advanced and treatment-resistant prostate cancer, as well as new knowledge gained from Moon Shot Program discoveries, to craft personalized profiles of patients’ tumors. These profiles will individualize treatment for prostate cancer patients, as well as validate new combination therapies and new drugs.